Administered by IV (through a vein) or by injection, these outpatient COVID treatments have been shown to reduce hospitalization or emergency room visits when received early. They have also shown to reduce viral load and reduce days of symptoms. We use the Sotrovimab authorized monoclonal antibody therapies which is manufactured by Glaxo Smith Kline.

Who Can Receive Monoclonal Antibody Therapy?

These medicines are authorized for use on people ages 12 and older. If they have tested positive for COVID-19 and meet other specific criteria, they may qualify.

For more information about these treatments, the specific criteria and potential side effects, please read the Patient Fact Sheet (GSK’s sotrovimab).